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Abstract
Neglected tropical diseases (NTD), particularly vector-borne diseases (VBD), account for a
large proportion of the global disease burden, and their control faces several challenges including
diminishing human and financial resources for those distressed from such diseases. Visceral
Leishmaniasis (VL), the second-largest parasitic killer in the world (after malaria) affects poor
populations in endemic countries and causes considerable cost to the affected individuals and
their society. Mathematical models can serve as a critical tool for understanding the driving
mechanisms of a NTD such as VL. The WHO promotes integrated control programs for VL
but this policy is not well supported by systematic quantitative and dynamic evidence and so
potential benefits of the policy are limited. Moreover, mathematical models can be readily
developed and used to understand the functioning of the VL system cheaply and systematically.
The focus of this research is three-fold: (i) to identify non-traditional but critical mechanisms
for ongoing VL transmission in resource limited regions, (ii) to review mathematical models
used for other infectious diseases that have the potential to capture identified factors of VL, and
(iii) to suggest novel quantitative models for understanding VL dynamics and for evaluating
control programs in such frameworks for achieveing VL elimination goals.
1 Introduction
Visceral Leishmaniasis (VL) is a neglected vector-borne infectious disease that is transmitted to
humans by infected sandflies and is the second-largest parasitic killer in the world after malaria
∗Corresponding author, e-mail: amubayi@asu.edu
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[1, 2]. If left untreated, most cases result in death within two to three years of clinical manifes-
tation. Most of the new cases (approximately 90%) occur in Bangladesh, Brazil, Ethiopia, India,
Nepal, South Sudan, and Sudan. VL is identified as a Neglected Tropical Disease by the WHO
because it is endemic in several poverty stricken regions of the world, although preventive measures
and successful treatment is common in most developed countries. Many people living in these
impoverished regions are daily-wage workers, for whom infection with a disease like VL restricts
the bread-winners’ ability to provide livelihood for their families. Moreover, the cost of treatment
and duration of stunted income pushes them into a vicious cycle of further hardship and irrecov-
erable financial deprivation. Although local government authorities and the WHO have devised
several control programs to lower the burden of VL in these regions, the VL endemicity always
creeps back after a brief period of relief. This ineffectiveness has been attributed to several factors,
including severe under-reporting of cases and death due to VL, lack of clarity in the etiology of
the disease, and limited estimation of reservoirs of the infection. Thus, the intensity and extent
of the control programs were in conflict with the magnitude of the true VL burden. With limited
resources available in many of the affected countries, mathematical modeling can help shed light on
several of these challenges cheaply (including identifying cost-effective driving mechanisms), as it
has done for other infectious diseases like malaria. Hence, immediate attention from the modeling
community is in dire need.
In the past, the WHO has set several elimination target dates for VL, which could not be achieved
in the Indian subcontinent. The primary reason for this shortcoming may be the ineffective imple-
mentation of policies in the face of a developing country’s infrastructure. Mathematical modeling
approaches in conjunction with model guided additional field research in India could be a turning
point for achieving optimal program implementation and may help to (1) quantify the “true” bur-
den of VL in Bihar where it has proven to be particularly difficult to eliminate, (2) investigate the
potential mechanisms for the spread of the Leishmania parasite, and (3) suggest optimal vector
control programs that may help in achieving the WHO goal of elimination of VL by the year 2017
[3]. The VL elimination program target is to reduce the annual incidence to less than 1 per 10,000 at
the district or sub district level in South Asia by 2017 (WHO). Currently, the incidence is around 20
cases per 10,000 [4, 5, 6]. Understanding the mechanisms driving the transmission dynamics of VL
may require the study of several factors, including complex interactions of multiple reservoir hosts,
environment-dependent vector dynamics, changes in political and public health policy, spread of
resistance to insecticides and drugs, and short and long term human migration patterns.
Since Sir Ronald Ross’ first paper using a mathematical model to study the transmission dynamics
of malaria in 1906, there have been many modeling studies focusing primarily on infectious diseases;
however, more studies are needed on neglected tropical diseases such as VL. One of the aims of
this study is to suggest mathematical modeling approaches for capturing identified regional issues
that may be critical in better evaluating control programs in resource limited settings, thereby,
assisting in the development of cost effective elimination strategies. We discuss specific features
of VL (including treatment availability, living conditions, effect of social status, and implemen-
tation cost of control programs) that should be incorporated into quantitative methods that can
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be effectively used to analyze control strategies for the disease. Carefully established and directly
relevant mathematical models are urgently needed for VL control in an effort to develop a suitable
tool to truly capture the complex dynamics of the disease within the given natural or man-made
environments and to achieve elimination goals. The assessment of a tropical disease risk must be
interpreted on the basis of local environment conditions, the effects of socioeconomic development,
and its capability to effectively sustain control programs.
2 Challenges for Leishmaniasis in Resource-Limited Regions
When considering the socio-economic challenges of a neglected tropical disease at the grassroots
level, the depth and complexity appears overwhelmingly varied. So, to better comprehend the
nature of obstacles, we classified some of the key issues in to the six categories viz., atmosphere,
access, availability, awareness, adherence and accedence (6 A-s), which in turn can be traced back
to lack of either inculcation or infrastructure. Each of these variables ultimately stems from the
sheer poverty and its viscious cycle with diseases in the affected region (Figure 1). In this review
we focus on the state of Bihar, which hosts 90% of India’s VL cases (WHO), and its neighboring
countries of Nepal and Bangladesh where the disease dynamics is similar. The categories are briefly
described below.
Figure 1: A viscious cycle of socio-economic challenges and difficulty to access disease interventions
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Atmosphere: In the state of Bihar, the worst affected areas are in remote agricultural villages.
Studies have revealed several living conditions positively correlated with higher prevalence of leish-
maniasis. In two independent studies, factors like mud plastered houses, vegetation and bamboo
near the house, and granary inside the house were found to significantly contribute to leishmani-
asis [7, 8]. Other systematic studies in the subcontinent with similar geographical settings (Uttar
Pradesh, India; West Bengal, India; Terai, Nepal; Mymensingh, Bangladesh) have found that liv-
ing conditions with cracked mud walls, damp floors, and close proximity to a water body are risk
factors for leishmaniasis. Also, a high density of occupants in a household with more than three
people per room were found to increase transmission [9, 10, 11, 12, 13, 8, 14, 15, 16]. Models
that have incorporated such features (house types, household size etc.) exists for other diseases
[17, 18, 19, 20, 21, 22].
It is well known that sand-fly bites thrive during the warmer months (March - June, October),
and late in the evening [23]. The role of climatic factors on transmission dynamics of vector-
borne diseases has been thoroughly studied in the literature [24, 25]. The hot Indian summer
in combination with lack of electricity often lead people to sleep outdoors, which increases the
number of sand-fly bites and hence the risk of contracting leishmaniasis [11, 13]. Understandably,
proper use of bed-nets have been found to have a protective effect on people across several studies
[9, 11, 12, 14, 15, 16] and sleeping on a cot (versus on the floor) also demonstrated a protective
effect. Models have shown that proximity to domesticated animals was found to play a complex role
in containing, spreading and serving as a possible reservoir of the parasite [26]. For example, some
studies found that proximity to livestock provided a protective effect against leishmaniasis [12, 13],
whereas in Uttar Pradesh, India, the risk of leishmaniasis was found to increase with increased
numbers of cattle in the vicinity of a household [11].
Access: Currently, therapuetic interventions for Kala-azar (Indian VL) are significantly subsidised
by the ministry of health in India (National Vector Bourne Disease Control Program’s Kala-azar
Elimination Initiative under the Govt. of India). There are 38 District Health Societies (DHS) inside
the state healthcare system (State Health Society) of Bihar. The DHS are further subdivided into
a number of block-Primary Health Centers (PHCs); the number of PHCs per DHS varies for each
DHS. Again, the PHC consists of Sub-Centers providing health care to a certain number of villages
(e.g. the Muzaffarpur district (population 3.7 million) has fourteen Block PHCs while the Kanti
Block (population 337,670, Census of India, 2001) has 48 Sub-Centers, each covering a population of
roughly eight thousand individuals [27]). PHCs, district hospitals and government medical colleges
are the sources of reported cases (National Vector Borne Disease Control Programme, 2009). The
private health sector includes not-for-profit and for-profit organizations. For-profit venues include
corporations (e.g., private nursing homes), trusts, stand-alone specialist services, pharmacy shops,
and self-appointed practitioners. Estimates suggest that 80% of the outpatients and 57% of the
inpatients are handled in the private sector (The World Bank report, 2001 [28]). NGOs usually
provide awareness and education programs, carryout research, and provide access to regular health
services. Ninety percent of Bihar’s population lives in rural areas where less than 1% of health
services are provided by not-for-profit/Non-Government Organizations (NGOs) (The World Bank,
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2001 [28]). Patients in rural areas travel on average much further for treatment than patients in
urban areas. Thus, access to healthcare can be tricky at present and efforts need to be made to
encourage the set-up of temporary mobile clinics in harder to reach areas and to encourage people to
seek out certified treatment. Bihar is the poorest state in India, where the “caste” (proxy for social
standing) of a person is born into affects almost every aspect of the social conduct he/she receives
their entire life. [29]. Martinez [30] found that the people of lower caste are consistently being
seen by a doctor at a more advanced stage of VL than those of a higher caste. In fact, most VL
patients in the disadvantaged caste see a doctor more than eight weeks post symptom onset, which
includes a larger spleen and lower hemoglobin level than normal. Thus, efforts need to focus more
on the people of lower caste to diminish the disparity in healthcare; only then can planned control
measures effectively reduce the overall burden of VL. Models considering underreporting of cases
due to treatment of patients by non-reporting private healthcare clinics and patients’ healthcare
seeking behaviors have been developed [31, 32].
Availability: The WHO recommends the use of a single dose of Amphotericin B as the first line
of treatment in the Indian sub-continent [33]. However, daily injections of Pentavalent Antimonials
(SSG) for 20-30 days and 15 injections of Amphotericin B every other day are still more widely
used in India (NVBDCP). The availability of drugs in a timely manner is dependent on several
factors including the affordability of a drug by the government, reasonable forecasting of the quan-
tity of drug required (to avoid shortage as well as waste), proper storage and distribution of the
drugs throughout the lengthy route from the manufacturer to the affected people, avoiding cheaper
counterfeit drugs and also drug legislation [34]. Mathematical models can capture each of these
features [35, 36] and study their role in the spread and transmission dynamics of VL.
Awareness: ‘Awareness’ can be defined as knowledge regarding the etiology of the disease which
would help local individuals to prevent infection and to look out for VL symptoms and seek medical
attention sooner rather than later. Figure 2 shows some social aspects for which awareness programs
may be needed as a prevention for VL. Lack of awareness causes a disease which is curable upon
treatment, to end up causing death. Even symptomatic VL-infected people mix in the population
freely, thus considerably increasing the chances of transmission. In a study on Nepal (which shares
a boarder with Bihar) by Rijal 2006 et al., it was found that affected people from the poorest
strata of the community preferred to visit a private doctor or local faith healer over public health
clinics, leading to higher costs for these individuals [37]. Moreover, debts aquired during this
period, in addition to lack of income (the earning adult being ill), creates a major financial abyss
which is almost impossible to recover from. Thus, it is not sufficient that the government provides
free treatment to the people, it is also necessary to disseminate that information in an effective
manner to every strata of people in the affected region. In a study in Brazil, significant awareness
was spread in communities through educating school children, who in turn were assigned to discuss
interventions mentioned in student’s homework assignments with their family members [38]. Models
have studied the role of awareness programs on transmission dynamics of diseases [39, 40].
Adherence: Non-adherence to treatment is a major factor contributing to the high development of
5
Figure 2: Cartoon reflecting social aspects on which awareness programs to control spread of VL
can be designed to reduce disease burden
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resistance to pentavalent antimonials in the population exposed to VL in the Indian sub-continent
[34], and subsequently resulted in it being discontinued as a first line treatment for VL. There are
two major factors which contribute to non-adherence in the region: lack of knowledge about the
consequences of incomplete treatment leads to patients stopping treatment once the symptoms are
relieved, and the financial loss due to reduced days of productivity while on therapy is a major
deterrent to continuing treatment. It has been well documented in a 2000-2010 cohort study in
Nepal that another disease, Post Kala-azar Dermal Leishmaniasis (PKDL), a sequel and reservoir
for VL, was more common in patients who were inadequately treated during VL versus the ones
who adhered to the full course of treatment. The overall prevalence of PKDL in SSG treatment was
2.9%, 0.3% in supervised and 4.5% in unsupervised treatment [41]. As observed by Rijal 2006 et al.,
loss of productivity implies no income at all for the poor families [37]. Farmers are unable to attend
to their fields, possibly during very important farming phases which results in lowered income for a
considerable period of time. Alot of people in the poorest section of society in Bihar are also daily-
wage earners and each missed day of work might present dire consequences for the entire family.
To survive this period, the family takes out loans from private lenders at high interest, ultimately
leading them to further poverty. Thus, it is important to inform the people that non-adherence
would lead to relapses which are harder to treat; although the burden of missed work is difficult
to accept in the immediate context, it is better ultimately for the family. Consequently, providing
financial assistance to affected families while their primary earning members are under treatment
may improve the outcome of VL control programs, by encouraging greater adherence to treatment.
Although there is a need for better models that can capture irregular treatment adherence levels
among patients, some simple models exist in the literature [42, 43, 44, 45].
Accedence: ‘Accedence’ is defined as the acceptance to undergo testing and treatment for PKDL,
which can occur in patients who have recovered from VL post-treatment caused by the same
pathogen. As reported by Desjeux et al. in 2013, patients with PKDL serve as a reservoir of VL
and it is unlikely that VL can be eradicated without addressing the issue of diagnosing and treating
PKDL [46]. In fact, aggressive measures are required to encourage people to consult a doctor in case
of any persistent skin lesions, and once diagnosed these should be treated with Amphotericin B,
which has been found effective in the Indian sub-continent. As reported by Thakur et al., attempts
were made to fast-track diagnosis and treatment of PKDL in several badly affected districts of
Bihar and yielded a very positive outcome [47]. However, in addition to the use of mathematical
modeling methods, these efforts need the support of the local governmental authorities to continue
and succeed where it is most needed.
It is evident that aggressive control measures are necessary to address every issue and to ultimately
alleviate the burden of VL from Bihar. However, several of the issues arise from limited resources
in the affected region and thus the control strategies should be carefully weighed by importance and
cost-effectiveness. Moreover, it is not only important to take drastic measures using the one-time
funds generated for this purpose, but it is essential that powerful and sustainable changes in the
system are established through easy and systematic ways of approaching the difficulties, which can
only be attained by identifying critical mechanisms of the system. Mathematical models are one
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of the best methods to cheaply and systematically identify driving factors.
3 Review of VL Mathematical Modeling Studies
Despite the incalculable harm and countless challenges leishmaniasis inflicts on populations around
the globe, only a handful of publications address the problems from a mathematical modeling
perspective. In fact, a recent review by Rock et al., which tabulates all mathematical models of
VL, found only twenty-four articles using mathematical models for VL, several of which used the
same base model structure [48]. Of these twenty-four articles, only seven addressed VL in the Indian
Subcontinent. Arguably, one of the greatest modeling challenges is the limited understanding of
the leishmania pathogen, the sandfly vector, and how disease manifests in humans. Dye et al.
[49] spear-headed the application of mathematical models to leishmania dynamics. The authors
developed a simple discrete-time model with Susceptible, Infected, and Resistant humans to study
the mechanism behind inter-epidemic periods observed in VL cases between 1875 and 1950 in
Assam, India. Counter to the existing theory of the time, the model demonstrated that the observed
inter-epidemic patterns could be explained by intrinsic factors in leishmania transmission. This
modeling effort also stressed the significance of PKDL and sub-clinical infections in determining
whether a region will have endemic or epidemic leishmaniasis. A few years later, Hasibeder et
al. [50] published a compartmental delay-differential equation model for canine leishmaniasis. This
model accounts for two types of dogs: those that will develop symptoms, and those that will remain
asymptomatic, following infection by a sandfly. The model also explicitly describes the infection
dynamics of the sandfly vector and considers a fixed delay representing the extrinsic incubation
period. The authors take a heuristic approach to derive a formula for the basic reproduction
number R0, the number of secondary sandfly infections resulting from a single infected sandfly, in
an otherwise fully susceptible population. Although this model addresses two important aspects of
the natural history of the disease that may be extended to human VL, namely the asymptomatic
human and infected vector populations, the model does not consider the asymptomatic population
to be an infectious reservoir, assumes constant human and vector population sizes, and omits the
effects of seasonality. The model does, however, introduce heterogeneous biting, determined by a
dog’s “occupation”. The mathematics developed in [50] was applied to age-structured serological
data for the dog population in Gozo, Malta in [51], and provided estimates for R0. This modeling
work was extended in [52] to include zoonotic transmission, that is, humans, dogs, and sandflies,
were explicitly modeled. Dye conducted a sensitivity analysis to determine which of three control
measures would be most effective in decreasing disease prevalence. Their results suggest vector
control and vaccination of the human or dog population would be more effective than treating or
killing infected dogs.
More recently, Stauch et al. developed a more comprehensive model of VL for the Indian subconti-
nent [53], and later extended it to include drug-resistant and drug sensitive L. donovani parasites,
with a focus on Bihar, India [54]. The model proposed in [53] extended the basic SIR model struc-
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ture for the human population by segmenting the infected stage into five distinct stages according
to an individual’s infection status determined by the results of three diagnostic markers. These
diagnostic markers were (1) PCR, the earliest infection marker, (2) DAT, which measures antibody
response, and (3) LST, which can detect cellular immunity. The model also includes treatment of
symptomatic VL cases, treatment failure, relapse characterized as PKDL, PKDL treatment, and
HIV-co-infection (described in their Supplementary materials). The sandfly population is mod-
eled using an SEI (Susceptible-Latent-Infectious) model. Treatment of VL is divided into first and
second-line treatment, and treatment-induced mortality caused by drug-toxicity is considered. The
model was fitted to data from the KalaNet trial using Maximum Likelihood. The authors explored
several intervention strategies, including treatment, active case detection, and vector control. Al-
though the authors warn that their model assumes homogeneous transmission, ignoring possible
clustering of cases within affected households, their modeling approach and parameter estimation
argues that the large asymptomatic reservoir precludes the ability for a treatment-only control
program to attain the desired target of less than 1 case per 10,000 individuals annually. Vector-
based control is much more promising, but the authors estimate it can only reasonably reduce VL
incidence to 18.8 cases per 10,000. Consequently, the authors emphasize the need for active case
detection, effective treatment of PKDL, and vector control to achieve VL elimination.
Based on the model in [53], and following up on their finding that treatment of VL does little to
reduce transmisson, Stauch et al. investigated the uncertainty in their parameter estimates and
explored the efficacy of different vector-based control measures in [55]. They estimated that R0
for VL is approximately 4.71 in India and Nepal, and that reducing the sandfly population by
79% via reduction of breeding sites, or reducing the sandfly population by 67% through increasing
sandfly mortality, are both sufficient to eliminate the L. donovani parasite in the human population.
The authors argue that recent evaluations of IRS (indoor residual spraying) efficacy suggest that
elimination should be possible, with the caveat that the situation may change if insecticide resistance
emerges. However, vector management using LLIN’s (long-lasting insecticide-treated nets) or EVM
(environmental management) would not be sufficient to achieve elimination. The authors emphasize
the need to study infection rates, the parasite dynamics in both the human and vector population,
animals serving as alternate hosts or potentially infection reservoirs, and the contribution of the
asymptomatic population. Furthermore, Stauch et al. suggest extensions of the deterministic
modeling framework to include heterogeneity and seasonality.
In [54], Stauch et al. extended the model in [53] to include both resistant and sensitive parasites.
The authors considered five mechanisms by which the fitness of the resistant strain may differ
from the sensitive strain: (1) increase probability of symptoms, (2) increase parasite load, (3)
increase infectivity of asymptomatic humans, (4) increase transmission from symptomatic and
asymptomatic host to vector, (5) increase transmission from vector to host. Simulations of this
extended model indicate that a treatment failure rate over 60% is required to explain observations
in Bihar. Furthermore, observations in Bihar cannot be explained without assuming an increase in
fitness in resistant parasites. The authors explain that it is more likely that the necessary additional
fitness is transmission-related rather than disease-related. Unfortunately, their results also suggest
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that once a more fit resistant parasite has been introduced, that parasite will eventually exclude
the sensitive parasite, even in the absence of treatment.
The work of Mubayi et al. [56] is the first to use a rigorous, and dynamic model to estimate
underreporting of VL cases at the district level in Bihar, India. The authors designed a staged-
progression model, composed of a system of nonlinear, coupled, ordinary differential equations. The
stage-progression model exploits the fact that the sum of n independent exponential distributions
with rate parameter λ is a gamma distribution with shape parameter n and scale parameter 1/λ
(Γ(n, 1/λ)), and captures the observed variability in the incubation period, infectious period, and
treatment duration. Furthermore, the authors address the differences between public and private
health care facilities in their treatment and reporting practices by assuming a fraction of infected
individuals p seek treatment in public health care facilities, and the remaining proportion seek
treatment in private clinics. Building an empirical distribution for this parameter p and deriving a
relationship between model parameters and monthly reported incidence data allowed the authors
to estimate the degree of underreporting for each district for the years 2003 and 2005. This model
analysis informed by incidence data revealed that districts previously designated as low-risk areas
for VL are actually likely to be high-risk: the true burden masked by underreporting.
ELmojtaba et al. presented a more classical approach to modeling VL, with a focus on Sudan, in
[57, 58, 59]. Because leishmaniasis in the Sudan is zoonotic, the authors included the dynamics of
an animal reservoir in [57]. This baseline model is extended in [58] to address parasite diversity, and
in [59] to explore the potential impact of mass vaccination in the presence of immigration.
All of these modeling efforts have either contributed to our understanding of VL or highlighted the
need for better data to construct and validate future models of VL. However, there are currently
no models, to the best of our knowledge, that attempt to link socio-economic factors, like the 6 A’s
discussed in Section 2, to disease transmission.
4 Bridging Socio-economic Factors and Mathematical Models
In this section, we provide some examples of published mathematical modeling studies where re-
searchers have attempted to incorporate some of the factors mentioned above and studied their
role in the transmission dynamics of infectious and physiological diseases. Existing models of vis-
ceral leishmaniasis, though limited in number, have incorporated some of the biological complexity,
contributing to a more developed understanding of the disease. However, to formulate applicable
control measure recommendations with cost-estimation, models which can simultaneously incorpo-
rate the discussed risk-factors explicitly would be necessary. Many of the techniques to incorporate
these factors individually can be drawn from the literature regarding heavily studied diseases like
HIV, malaria, and tuberculosis.
In a simplistic mathematical model we can incorporate several risk factors associated with ambience
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implicitly through the interpretation and calculation of the model parameters. For example, the
transmission parameter can be considered as a product of the predominant type of housing, density
of vegetation around houses, number of domesticated animals, and number of inhabitants in a
house.
Lipsitch et al. addressed adherence to treatment and its role in promoting drug resistance in a
mathematical model for tuberculosis (TB) in the presence of bacterial heterogeneity [60]. To model
non-compliance to drug therapy, the authors assumed that non-compliant patients adhere to the
treatment regimen when bacterial loads are above a certain threshold, and will halt treatment when
bacterial loads fall below this threshold, that is,
Adherence level(t) =
{
αB(t)
K+B(t) ifB(t) ≥ Nmin
0 ifB(t) < Nmin
where B(t) is the bacterial load at time t and Nmin is the theshold minimum bacterial load under
which drug treatment is discontinued. Simulation and analysis of their stochastic-deterministic
hybrid model illustrated that non-compliance is one mechanism that can give rise to bacteria
resistant to one or more drugs in a multi-drug therapy. Furthermore, the authors noted that the
pattern of resistance driven by non-compliance more closely resembled observations of patients on
multi-drug therapy, compared with the pattern of resistance promoted by bacterial heterogeneity.
Consequently, the model suggests that non-compliance plays a larger role than heterogeneity of the
bacteria population in promoting resistance during multi-drug therapy. The authors noted that
an exception to this pattern occurred in HIV-positive TB patients. The modeling assumption for
non-compliance in this TB model addresses one of the ‘adherence’ concerns discussed in Section
2, namely that patients often stop treatment once symptoms are relieved, suggesting a possible
framework in which to study adherence to treatment, treatment failure, and if tied to a population-
level model, the spread of drug resistant parasites in VL-endemic regions.
Adherence to treatment is also a concern in diabetes patients, despite the fact that non-adherence
increases the likelihood for stroke and other potentially fatal complications. Mason et al. [61]
developed a Markov Decision process (MDP) model to study the timing of treatment initiation and
drug-adherence in diabetes patients and the role these two factors play in determining a patients’
quality-adjusted life years (QALYs). Consistent with observations of adherence behavior in diabetes
patients, the model assumed that a patient’s health status does not influence future adherence. This
assumption may be relevant for some VL-endemic regions where non-adherence is a consequence
of insufficient inculcation of the risks associated with improper treatment, or a result of the cost
of treatment. The model also assumed, consistent with clinical practice, that if a patient or the
patient’s physician had not already decided to begin treatment, treatment would be immediately
initiated following a non-fatal complication. The reward function, dependent on adherence, included
several important factors, including QALY, the cost of treatment and hospitalization, and disutility
resulting from treatment side effects. The authors also developed a cost function, with the goal of
optimizing treatment initiation, in the presence of different degrees of non-adherence, and compared
11
Figure 3: General categories of modeling frameworks for studying dynamics of vector-borne diseases
and types of data needed in such frameworks
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the optimal timing for ‘uncertain adherence’ and ‘predictable adherers’. The authors quantified
the benefit of treatment relative to the cost through a reward function rt(l,m), where l denoted
the patient’s health status, and m equaled zero or one, depending on whether the patient was on
treatment or not.
rt(l,m) = R(l,m)− C
0
t − (CF
S(l) + CFCHD(l))−mCST (A)− (CS(l) + CCHD(l)),
for t = 1, . . . , T − 1, l ∈ L,m ∈M, where
R(l,m) = R0(d
S(l))(dCHD(l))(mdST (A)), l ∈ L, m ∈M
describes the reward for 1 quality-adjusted life. The decrement factors dS , dCHD, and dST denote
the decrease in quality of life from a stroke (S), a coronary heart disease (CHD) event, or statins
initiation (SI), respectively. The costs CO, CST , CS and CCHD, and CFS and CFCHD represent
the cost of other health care for diabetes patients, cost of statin treatment, cost of initial hospi-
talization for stroke and CHD events, and cost of follow-up treatment for stroke and CHD events,
respectively. This diabetes model suggested that initiation of treatment should be delayed in indi-
viduals predicted to have poor future adherence. Furthermore, the model predicted that over time,
only 25% of patients will remain adherers for greater than 80% of the days during the study.
The effect of change in disease dynamics due to behavioral change and educational awareness have
been modeled using ordinary differential equations-based models in several studies. Hallett 2009
analyzed the effect of behavior change on the course of an HIV epidemic [62]. In their dynamic
model, the behavior is incorporated by considering parameters such as mean rate of partner change
and condom use in casual relationship as a step-function depending on time at which the change
in behavior occurred and time it takes to reach a new value. In Mushayabasa 2012, an ordinary
differential equation model was used to quantify the role of an educational campaign in controlling
Hepatitis C among women in prison [63]. Here, the effect of this campaign is reflected as an efficacy
factor in conjunction to the parameters which represent the sharing of contaminated needles or
syringes among the susceptible and exposed classes.
Ideas for VL modeling should also draw from modeling techniques used in economics in the context
of social sciences to effectively optimize the cost and strategy in a resource-limited region. Fenichel
et al. used an economic behavioral model in conjunction with the classical Susceptible-Infected-
Recovered (SIR) model that explicitly models adaptive contact behavior [64]. The authors construct
a utility function, an index which describes an individual’s well-being. The framework assumes
that individuals make choices that maximize their utility. These decisions then impact disease
risk, creating a feedback loop between disease risk and decisions made based on perceived disease
risk. The authors demonstrate that fitting the classical SIR model to data generated by their new
framework results in erroneous estimates of epidemiological parameters, because of its inability to
jointly estimate behavioral and biological parameters. See Perrings et al. for a thorough review on
the growing topic of economic epidemiology [65].
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A study by Gorahava et al. develops a dynamic optimization model to suggest novel ways of al-
locating insecticides in the districts based on sizes of both human and cattle populations while
considering limited financial and resource constraints [26]. The model maximizes number of sand-
flies killed by insecticides intervention and minimizes number of human cases while identifying
optimal number of houses and cattle sheds to be sprayed for a given budget.
The results of the above models addressing adherence to treatment, adaptive human behavior,
and resource constraints emphasize the need to bridge the gap between socio-economic factors and
existing VL modeling frameworks. The 6 A’s should be systematically incorporated into VL model
frameworks to assess the sensitivity of model dynamics to these six socio-economic factors. Failing
to address factors that result in significant changes in disease dynamics may result in models that
do not effectively inform public health policy. Likewise, models that do not acknowledge resource
constraints may lead to infeasible control policies.
5 Discussion
Leishmaniasis continues to spread in every continent on the planet except Australia and Antartica,
and VL is most common in the poorest regions of modern human civilization. The WHO has iden-
tified leishmaniasis as a neglected tropical disease owing to its endemicity in the under-developed
tropical regions of the world, in spite of available treatment options in first world countries. The
reason for the ongoing spread and failure to control lies mainly in underreporting of the disease
burden [31], poor infrastructure, lack of awareness, poverty and inadequate control measures. In
this review we have presented some of the less highlighted, but nonetheless very important, factors
which are key in one of the VL affected neglected regions, the Indian state of Bihar, and possibly
in several other impoverished regions; these factors may also play a critical role in the transmission
of other NTDs [31].
Mathematical models have been used to understand disease dynamics in other parasitic infections
and recommend control measures under different constraints. Thus, we propose mathematical
modeling as a cheap and effective tool to devise meaningful control measures that will make the
next WHO leishmaniasis elimination goal a reality. Most of the mathematical modeling research
on leishmaniasis has focused on the development and choice of drugs and co-infection with other
diseases [66, 48, 54]. Although the importance of these topics cannot be overlooked, more attention
needs to be focused on socio-economic issues leading to lack of infrastructure, inculcating awareness,
and promoting healthier practices. In this article we identified key issues relating to these factors
as observed and published in the literature. We also reviewed current mathematical models used
for leishmaniasis and discussed some ways of explicitly incorporating these socio-economic issues
into mathematical models. In light of the major financial constraints in the affected regions, a
hybrid dynamic optimization model (an example framework is shown in Figure 3) will be necessary,
which can calculate monetary (cost of interventions) and non-monterary (mortality and morbidity)
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factors related to VL for the specific region taking into consideration the socio-economic drawbacks.
The building of such a model will require detailed quantification of every aspect of life in the
regions, including non-tangible issues. Moreover, the execution of this model will require extensive
sets of data on these varied aspects, which can be challenging considering the current dearth of
data. However, in absence of data, projections can be made for different scenarios to elucidate
an understanding of the magnitude of the problem, and to estimate the relative importance of
different socio-economic factors to accurately predicting disease dynamics and informing effective
public health policies.
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